mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dusting, GJ; Liu, GS; Peshavariya, HM; Shah, MH; Thompson, EW | 1 |
| Al-Enezi, KS; Alkhalaf, M; Benov, LT | 1 |
2 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Breast Neoplasms
| Article | Year |
|---|---|
Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells.
Topics: Antioxidants; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Hydrogen Peroxide; MCF-7 Cells; Metalloporphyrins; NF-kappa B; Organometallic Compounds; Salicylates; Signal Transduction; Superoxides | 2015 |
Glycolaldehyde induces growth inhibition and oxidative stress in human breast cancer cells.
Topics: Acetaldehyde; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Lipid Peroxidation; Metalloporphyrins; Oxidative Stress; Phenanthridines; Superoxides; Tumor Suppressor Protein p53 | 2006 |